Peptide-based nanoprobes for molecular imaging and disease diagnostics

Area of Science:

• Biomolecular chemistry
• Nanotechnology
• Medical diagnostics

Background:

• Pathological changes involve abnormal biomolecule activity, crucial for disease diagnosis and treatment.
• Early identification of biomolecules aids disease diagnosis, treatment strategy design, and outcome assessment.
• Peptide-based nanoprobes (PBNs) have evolved over 20 years to enhance molecular probe performance.

Purpose of the Study:

• To review strategies for identifying functional peptides in molecular imaging and diagnostics.
• To discuss the design and construction of PBNs for improved physiological barrier navigation.
• To highlight the role of peptides in PBN design for enhanced target recognition and clinical translation.

Main Methods:

• Review of strategies for functional peptide identification in molecular imaging.
• Analysis of PBN design principles for targeted delivery and enhanced specificity.
• Discussion of peptide roles in PBN construction and their biological/structural significance.

Main Results:

• PBNs engineered through structural and physicochemical property modifications improve in vitro and in vivo probe performance.
• PBNs can be designed to navigate physiological barriers, enhancing targeted delivery.
• Optimized PBNs demonstrate improved specificity and sensitivity in recognizing target biomolecules.

Conclusions:

• Peptide-based nanoprobes represent a promising platform for molecular imaging and disease diagnostics.
• Strategic design of PBNs, leveraging peptide properties, is key for clinical translation.
• Future developments in PBNs hold potential for significant advancements in medical diagnostics and treatment monitoring.